{"schema_version":"1","generated_at":"2026-11-05T01:02:16.567Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sumana-devata","json_url":"https://www.findmykol.com/kol/sumana-devata/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sumana-devata","name":"Sumana Devata","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Medical College of Wisconsin","institution_url":"https://www.findmykol.com/institution/medical-college-of-wisconsin","city":"Milwaukee","state":"WI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1265609564","openalex":"A5047177351"},"summary":"Sumana Devata is an Oncology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 84 publications with 1,122 citations (h-index 17).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":84,"cited_by_count":1122,"h_index":17,"latest_activity_year":2025,"emerging":true,"source":"works"},"prescribing":{"data_year":2023,"areas_total":2,"areas_shown":2,"areas":[{"area":"Dermatology","share_pct":62.7,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":62.7,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":11}]},{"area":"Metabolism & gastrointestinal","share_pct":37.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":37.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Surovatamig (AZD0486), a CD19xCD3 T-cell engager (TCE), demonstrates high rate of minimal residual disease (MRD)–Negative complete responses in Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL), including in patients who previously progressed on CD20 TCE and CD19 CAR T-cell therapies","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-5514","status":"verified"},{"title":"Safety and efficacy of AZD0486, a CD19xCD3 T-cell engager, in relapsed or refractory diffuse large B-cell lymphoma.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.7046","status":"verified"},{"title":"227 | RITUXIMAB AND EPCORITAMAB AS FIRST‐LINE THERAPY FOR PATIENTS WITH HIGH‐TUMOR BURDEN FOLLICULAR LYMPHOMA: FIRST RESULTS OF A MULTICENTER PHASE II TRIAL","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70094_227","status":"verified"},{"title":"Escalating Doses of AZD0486, a Novel CD19xCD3 T-Cell Engager, Result in High Complete Remissions with Rapid Clearance of Minimal Residual Disease in Patients with Relapsed/Refractory Follicular Lymphoma","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-193589","status":"verified"},{"title":"Evaluation of AZD0486, a Novel CD19xCD3 T-Cell Engager, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in an Ongoing First-in-Human Phase 1 Study: High Complete Responses Seen in CAR-T-Naive and CAR-T-Exposed Patients","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-193681","status":"verified"}],"source":"works"},"similar":[{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Razelle Kurzrock","slug":"razelle-kurzrock","institution":"Medical College of Wisconsin","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/razelle-kurzrock","json_url":"https://www.findmykol.com/kol/razelle-kurzrock/profile.json"},{"name":"Mary Horowitz","slug":"mary-horowitz","institution":"Medical College of Wisconsin","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/mary-horowitz","json_url":"https://www.findmykol.com/kol/mary-horowitz/profile.json"},{"name":"David Gutterman","slug":"david-gutterman","institution":"Medical College of Wisconsin","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-gutterman","json_url":"https://www.findmykol.com/kol/david-gutterman/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}